From Self-sufficiency
Jump to: navigation, search
Systematic (IUPAC) name
Pharmacokinetic data
Biological half-life 5.2 ± 1.7 (range 0.4 to 5.5) minutes
CAS Number 86-42-0
ATC code P01BA06 (WHO)
PubChem CID 2165
DrugBank APRD00796
ChemSpider 2080
Chemical data
Formula C20H22ClN3O
Molar mass 355.861 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Amodiaquine (trade names Camoquin, Flavoquine) is a 4-aminoquinoline compound related to chloroquine, used as an antimalarial and anti-inflammatory agent.

Amodiaquine has been shown to be more effective than chloroquine in treating CRPF (chloroquine-resistant Plasmodium falciparum) malaria infections and may afford more protection than chloroquine when used as weekly prophylaxis. Amodiaquine, like chloroquine, is generally well tolerated. Although licensed, this drug is not marketed in the United States but is widely available in Africa. Its use, therefore, is probably more practicable in long-term visitors and persons who will reside in Africa.[1]

Amodiaquine is a histamine N-methyltransferase inhibitor.


Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />

de:Amodiaquin fa:آمودیاکین
  1. CDC recommendations for travel to areas with malaria